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This study identified the prevalence and predictors of fatigue in colorectal cancer (CRC) patients. 
Cross-sectional study with 157 adult CRC outpatients (age 60±11.7 years; 54% male; cancer stage 
IV 44.8%). The Piper Fatigue Scale-revised was used to assess fatigue scores. Socio-demographic, 
clinical, depression, performance status, pain and sleep disturbance data were assessed. Associations 
between fatigue and these data were analyzed through logistic regression models. Fatigue was 
reported by 26.8% patients. Logistic regression identified three predictors: depression (OR: 4.2; 
95%CI 1.68-10.39), performance status (OR: 3.2; 95%CI 1.37-7.51) and sleep disturbance (OR: 
3.2; 95%CI 1.30-8.09). When all predictors were present, the probability of fatigue occurrence 
was 80%; when none were present, the probability was 8%. The model’s specificity and sensitivity 
were 81.9% and 58.6%, respectively. Through the assessment of depression, performance status 
and sleep disturbance, the probability of fatigue occurrence can be estimated, and preventive and 
treatment strategies can be rapidly implemented in clinical practice.
Descriptors: Colorectal Neoplasms; Odds Ratio; Regression Analysis; Risk Factors; Signs and 
Symptoms.
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Fadiga em pacientes com câncer colorretal: prevalência e fatores associados
Os objetivos deste estudo foram identificar a prevalência e os preditores de fadiga em pacientes 
com Câncer Colorretal (CCR). Trata-se de estudo seccional com 157 pacientes ambulatoriais 
com CCR (idade 60±11,7 anos; 54% homens; estádio câncer IV 44,8%). A Escala de Fadiga de 
Piper - Revisada foi utilizada para avaliar fadiga. Dados sociodemográficos, clínicos, depressão, 
funcionalidade, dor e sono foram avaliados. A associação entre variáveis foi realizada por 
regressão logística. Fadiga foi reportada por 26,8% pacientes. Pela regressão logística 
identificaram-se três preditores: depressão (OR: 4,2; 95%IC 1,68-10,39), funcionalidade 
(OR: 3,2; 95%IC 1,37-7,51) e prejuízo do sono (OR: 3,2; 95%IC 1,30-8,09). Quando todos 
preditores estavam presentes, a probabilidade de ocorrência de fadiga foi de 80%; quando 
nenhum estava presente, a probabilidade foi de 8%. A especificidade e sensibilidade do 
modelo foram, respectivamente, 81,9 e 58,6%. Conhecendo-se a probabilidade de fadiga, 
por meio da avaliação de depressão, funcionalidade e prejuízo do sono, torna-se possível a 
implementação de estratégias de prevenção e tratamento na clínica.
Descritores: Neoplasias Colorretais; Razão de Chances; Análise de Regressão; Fatores de 
Risco; Sinais e Sintomas.
Fatiga en pacientes con cáncer cuello rectal: superioridad y factores 
asociados
Los objetivos de este estudio fueron la identificación de la superioridad y los predictores de 
fatiga en pacientes con Cáncer Cuello rectal (CCR). Se trata de estudio seccional con 157 
pacientes de ambulatorio con CCR (edad 60±11,7 años; 54% hombres; estadio cáncer IV 
44,8%). La Escala de Fatiga de Piper - Revisada fue utilizada para evaluar fatiga. Datos 
sociodemográficos, clínicos, depresión, funcionalidad, dolor y sueño fueron evaluados. La 
asociación entre variables fue realizada por regresión logística. Fatiga fue reportada por 
26,8% pacientes. Por la regresión logística se identificaron tres predictores: depresión (OR: 
4,2; 95%IC 1,68-10,39), funcionalidad (OR: 3,2; 95%IC 1,37-7,51) y perjuicio del sueño 
(OR: 3,2; 95%IC 1,30-8,09). Cuando todos predictores estaban presentes, la probabilidad 
de ocurrencia de fatiga fue del 80%; cuando ninguno estaba presente, la probabilidad 
fue del 8%. La especificidad y sensibilidad del modelo fueron, respectivamente, 81,9 y 
58,6%. Conociéndose la probabilidad de fatiga, por medio de la evaluación de depresión, 
funcionalidad y perjuicio del sueño, se vuelve posible la implementación de estrategias de 
prevención y tratamiento en la clínica.
Descriptores: Neoplasias Colorrectales; Oportunidad Relativa; Análisis de Regresión; 
Factores de Riesgo; Signos y Síntomas.
Introduction
For a long time, fatigue in cancer has been studied 
as an isolated symptom. There were studies that aimed 
to identify its prevalence, the evolution according to the 
course of the disease, different treatments for cancer 
and treatments for fatigue. As these pieces of knowledge 
seemed relevant, new studies tried to identify the factors 
that could predict the presence and intensity of fatigue. 
Studies that investigate the tumor site as a risk factor 
for fatigue or focus on patients with a single disease site 
are important for the development of diagnostic strategies 
and targeted fatigue interventions. Few studies have 
investigated fatigue in colorectal cancer patients, and 
none has identified predictors of fatigue in these patients. 
Thus, aiming to fill this gap, this study was undertaken 
to identify predictive factors of fatigue in patients with 
colorectal cancer.
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The prevalence of fatigue is undoubtedly high. 
In a systematic review that included 27 studies, the 
prevalence ranged from 4% to 91%, depending on 
the cancer population and assessment instruments(1). 
Specifically in patients under cancer treatment, it ranged 
from 32% to 99%(2). The intensity of the symptom is 
also considerable, with mean scores ranging from 2.6 
to 6.9, depending on the cancer site and staging(3-4). 
Fatigue seems to persist even after the “cure” of cancer, 
since 19% to 58% of treated people without evidence of 
cancer reported the symptom(5-6).
Fatigue is a deleterious symptom that causes 
suffering, distress, functional limitation and predicts 
overall survival and quality of life(7-9). Many factors 
may be related to the occurrence or aggravation of 
the symptom and recent studies have investigated 
predictors of cancer-related fatigue in non-specific 
site groups, such as advanced cancer, outpatients 
and cancer survivors. It shows that, according to the 
disease stage, the associated factors may vary. It 
seems that, in outpatients, the predictors include a 
reasonable amount of socio-demographic variables 
(female gender, high education, having a regular job 
and living without a partner), besides depression and 
performance status(10-12). On the other hand, fatigue-
associated factors in patients with advanced cancer are 
basically related to other signs and symptoms present 
in terminally ill patients (e.g. pain, dyspnea, decreased 
appetite, depression, weakness sensation, anxiety, low 
hemoglobin levels and others)(3-4,13-14). Interestingly, 
among cancer survivors, fatigue predictors include not 
only performance and symptoms, but also cognitive 
impairment (stress, coping, self-efficacy)(5).
From the description, a vast variety of physiological, 
physical, emotional, affective, socio-demographic and 
treatment-related predictive factors are noted. Yet, it 
was observed that many studies involved patients with 
cancer in various sites and that, in those that included 
patients with different tumors, the tumor site was not a 
predictive factor. Therefore, this paper specifically focused 
on colorectal cancer patients’ fatigue experience, aiming 
to investigate its prevalence and independent associated 
factors.
Methods
Cross-sectional study, involving 157 Brazilian adults 
with primary colon or rectal cancer. Inclusion criteria were: 
age 18 or more, being treated or followed in outpatient 
oncology services (inpatients were not included). To 
have or not fatigue was not an inclusion criteria. These 
subjects composed a convenience sample and were 
recruited from four outpatient oncology services at Sao 
Paulo city (1 public, 2 private and 1 both), July/2006 to 
July/2007. The sample representation from each service 
ranged between 15.3% and 33.1%. The number of 
patients that refused to participate was considered low 
(8 patients).
Oncologists identified the subjects at the participating 
oncology services. After a medical appointment, the 
researcher recruited the patients, checked the inclusion 
criteria and invited them to participate in the study. All 
participants signed the informed consent term and the ethics 
committees of each of the institutions involved approved 
the study. Socio-demographic data and data related to the 
cancer, its treatment, concomitant medication and clinical 
signs/symptoms were obtained through interview and 
medical chart analysis. Pain and sleep disturbance were 
assessed on a numerical scale (0-10 scale). Performance 
status (ability to perform daily activities) was assessed 
using the Karnofsky Performance Status Scale (KPS). 
Depression was assessed through the Beck Depression 
Inventory (BDI). It is a self-report instrument that consists 
of 21 items to evaluate depressive symptoms. Each item is 
scored from 0 to 3 and the total BDI score varies between 
0 and 63. Scores between 16 and 20 account for dysphoria 
and above 21 for depression(15). In the current study, 
Cronbach’s alpha equaled 0.83.
The Piper Fatigue Scale (PFS) - revised is a 22-item 
self-report instrument with three dimensions (behavioral, 
affective and sensorial/psychological). Each item is scored 
on a numerical scale (0-10). The dimension scores and total 
score vary between 0 and 10 and are obtained by adding 
up the score of each item and dividing this by the number 
of items on each dimension, or by 22 when calculating 
the total score. This instrument was validated for use in 
Brazilian cancer patients and the internal consistencies for 
the total scale (Cronbach’s alpha=0.94) and its dimensions 
(Cronbach’s alpha between 0.84 and 0.94) were very 
good in this study sample(16). The correlation between 
fatigue intensity on the numerical scale (0 to 10) and the 
Piper Fatigue Scale-revised (0 to 10) was also very good 
(Pearson r=0. 748; p<0.001). Fatigue was analyzed as a 
nominal variable and the cut-off point was established at 
score 4 (<4 = no fatigue; ≥4 = with fatigue), based on the 
consensus of the National Comprehensive Cancer Network 
(2007)(17) and on the percentile distribution of the Piper 
scores, based on the present study findings.
When the subjects finished answering the self-report 
instruments, the researcher checked for missing data 
and, in case data were missing, the researcher handed 
the items back to the subjects so they could complete the 
instrument. Nevertheless, missing data occurred. On the 
BDI, a total of two items were blank and the mean score 
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of that item all other subjects had answered was used to 
replace the missing data. On the PFS, three items were 
blank and the patient’s mean subscale score of all items 
in the same dimension was used to replace the missing 
data. Missing socio-demographic, clinical, treatment data 
were left blank.
For univariate analysis, Chi-Square test, Likelihood 
Ratio, Mann-Whitney test or T-Test were done. The 
variables that were associated to fatigue were inserted in 
the logistic regression model. The quantitative variables 
were analyzed through ROC curves to establish cut-off 
scores based on these study findings, and they were pain 
(cut-off score=6.0), sleep disturbance (cut-off score=5.0), 
performance status (cut-off score=80%), and depression 
(cut-off score=13). The variables were inserted in the 
logistic regression model, using forward stepwise. The 
Statistical Package for the Social Sciences-version 15.0 
was used to perform the analyses and p<0.05 was preset 
for statistical significance. 
Results
Socio-demographic, clinical, disease and treatment 
characteristics
There was a slight predominance of men (n=85; 
54.1%), married (n=107; 68.2%) and white (n=102; 
65.0%). Most subjects were middle-aged adults (41-64 
years), and the mean age was 60.0 (±11.7), varying from 
28 to 84. In terms of formal education, over half of the 
participants studied over 9 years (n=102; 65.0%). Most of 
them were not employed (n=112; 71.3%) and 113 (72.0%) 
were being assisted in private oncology clinics. The clinical 
characterization of the participants is presented in Table 1.
In Table 1, a significant portion of subjects with altered 
BMI (57.6%) can be observed. Of 157 subjects, 110 (70.1%) 
had colon tumors (data not shown in Table), and the others 
had rectal cancer. Many of the subjects had advanced stage 
disease (III and IV) and almost all received chemotherapy 
and/or radiotherapy. Nearly half of the patients (55%) 
had co-morbidities and 20% used antidepressants and/or 
anxiolytics. Scores compatible with dysphoria and depression 
were present in 15.4% of the subjects. 
Prevalence of fatigue
Almost half of the patients (n=78; 49.7%) reported 
no fatigue at all (zero score). Mild, moderate and severe 
fatigue was reported by 37 (23.5%), 35 (22.4%) and 7 
(4.4%) patients, respectively. Considering that clinically 
significant fatigue was present when the total PFS score 
≥4, 26.8% (n=42) of the patients reported fatigue. 
Among those who reported fatigue, the mean score was 
5.8 (SD=1.3), the median 5.4 and the minimum and 
maximum scores 4.2 and 9.6.
Patients
N %
- Anxiolytics 16 13.3
- Antidepressants 16 13.3
Colostomy (n=155)
No 99 63.9
Clinical staging (n= 134)
I 12 9.0
II 29 21.6
III 33 24.6
IV 60 44.8
Present treatment for cancer (n=157)
Not undergoing treatment 54 34.4
Receiving treatment 103 65.6
- Chemo and/or radiotherapy 99 96.1
- Other treatments (hormone, 
bisphosphonate, etc) 4 3.9
Surgery (n=156)
Undergone surgery (n=148) 148 94.9
Mean time in months since surgery 
(SD); median; min-max 23.5 (±37.0); 7.0; 1-240
Performance Status (n=153)
Mean (SD); median; min-max 86.7 (±12.4); 90.0; 50-100
Presence of pain (n=157)
Yes 55 35.0
Mean (SD); median; min-max 4.6 (±2.1); 4.0; 1- 10
Sleep Disturbance (n=156)
Yes 60 38.5
Mean (SD); median; min-max 5.9 (±2.4); 6.0; 1 -10
Depression (n=156)
Mean (SD); median; min-max 9.3 (±7.1); 9.0; 0-37
Table 1 - (continuation)
(continue...)
Table 1- Patients’ clinical characteristics
Patients
N %
BMI (n=151)
Underweight (<18.5) 3 2.0
Normal (18.5 – 24.9) 64 42.4
Overweight (25.0-29.9) 63 41.7
Obese (30.0-39.9) 21 13.9
Mean (SD); median; min-max 25.5 (±4.0); 25.6; 13.6-36.3
Hemoglobin level (n=124)
No anemia 88 71.0
Mean (SD); median; min-max 13.1 (±1.7); 13.1; 9.8-17.0
Co-morbidities (n=157)
Yes 87 55.4
Medication (n=157)
Yes 120 76.4
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Associated and predictive factors
In univariate analysis, fatigue showed association 
with five out of twenty investigated variables: to be 
assisted at a public hospital, pain, sleep disturbance, 
depression and performance status. These five variables 
The sensitivity of the model identified in this study 
was 58.6%. The specificity level equaled 81.9%. These 
data indicate that, by using the Fatigue Prediction Table, 
constructed in this study, the chance to correctly identify a 
fatigued person is approximately 60%, against approximately 
82% to correctly identify a person who is not fatigued.
Discussion
The identification of fatigue predictors permits the 
prevention, early diagnosis and development of specific 
actions for its control. Little was known on the prevalence 
of fatigue in colorectal cancer patients and there were no 
studies on fatigue predictors in this population, which was 
achieved in this search.
In general, the study sample is similar to other 
studies on colorectal cancer patients concerning socio-
demographic, clinical and treatment data(18-19). The data 
was collected at four oncology services with different 
characteristics (public and private, hospitals and outpatient 
clinics) and this improved the representation of patients 
with colorectal cancer. Although a randomization of the 
sample was desirable, that was not feasible. Thus, the 
option of using four different oncology services increased 
external validity.
Variable Estimated error (β) Standard error Odds Ratio 95% CI P
Health service 0.429
Private (0) x Public (1)
Pain 0.302
No (0) x Yes (1)
Pain 0.093
Score <6 (0) x Score ≥6 (1)
Sleep disturbance 0.964
No (0) x Yes (1)
Sleep disturbance 1.176 0.467 3.241 1.299 8.087 0.012
Score <5 (0) x Score ≥5 (1)
Depression 0.670
W/O depression(0) x Dysphoria(1) 0.543
x Depression (2) 0.868
Depression 1.430 0.465 4.180 1.681 10.393 0.002
Score <13 (0) x Score ≥13 (1)
Performance status 1.167 0.433 3.212 1.373 7.511 0.006
Score >80% (0) x Score <80% (1)
Table 2- Logistic regression model for fatigue (n= 151)
(1) Reference category
Sleep 
Disturbance
Performance 
status Depression
Probability of Fatigue 
occurrence
0 0 0 0.082489
1 0 0 0.224088
0 1 0 0.225308
0 0 1 0.271307
1 1 0 0.483007
1 0 1 0.544631
0 1 1 0.546366
1 1 1 0.79462
Table 3 - Fatigue Prediction Table: probability of fatigue 
occurrence in the presence of independent predictive factors*
*0 = no; 1= Yes
Utilizing the estimated error for each of the 
independent predictive variables, the Fatigue Prediction 
Table (Table 3) could be constructed. This Table shows 
the probability of the individual to have fatigue based 
on the presence/absence of each variable. Patients who 
do not have any of these predictors have approximately 
8% chance of having fatigue and those with the three 
independent predictors have approximately 80% chance. 
It is observed that not only the number of factors, but also 
their nature influences the likelihood of having fatigue. 
Depression increases the likelihood of having fatigue more 
than the other factors (Table 3).
were included in the multiple regression model (Table 2) 
and three independent predictors for fatigue were 
identified: sleep disturbance, depression and performance 
status. The risk for fatigue was higher for depression 
(OR=4.2) than for sleep disturbance (OR=3.2) and 
performance status (OR=3.2).
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The cut-off score of 4 or higher, which refers to the 
percentile 25 of the fatigue score distribution and meets 
National Comprehensive Cancer Network criteria(17), 
represents the fatigue present in 75% of the sample. In 
the literature review, it was noted that other authors also 
adopted the same cut-off score(20), which is beneficial to 
standardize and compare assessments. In addition, having 
fatigue cut-off scores higher than 1, 2 or 3 contributes 
to assuring that fatigue has clinical relevance, which may 
not occur with lower cut-off scores related to minimum 
discomfort.
No studies on fatigue predictors in colorectal cancer 
patients were found, but the study data on fatigue 
prevalence and intensity were similar to those used in 
this search(18-19,21). When fatigue prevalence (26.8%) 
and intensity (mean=5.8; SD=1.3; median=5.4) in 
this research were compared to studies involving other 
cancer patients, it was noted that fatigue was less 
frequent than in studies on patients in palliative care and 
receiving adjuvant chemotherapy or radiotherapy(1-2), 
and higher than some cancer survivors’ experience, 
who reported 26%(8). A slightly higher prevalence of 
fatigue (33%), using the same cut-off score as this 
study, was observed among colorrectal cancer patients 
in the United Kingdom(22). This higher prevalence might 
be due to the instrument used for fatigue assessment. 
In a Turkish study that proposed an intervention for 
cancer-related fatigue among intervention group 
patients undergoing chemotherapy, the baseline 
fatigue score assessed through the Piper Fatigue 
Scale was 3.5(23). These researchers probably included 
scores from all patients, lowering the mean score when 
compared to the present study.
The univariate and multivariate analysis identified 
the risk and predictive fatigue factors. The only socio-
demographic risk factor was the “public health service”. 
No study was found that analyzed the relationship 
between fatigue and health service, probably because 
the majority of published studies include subjects who 
live in developed countries, where the quality of health 
services is similar, independently of the provider. 
Pain, sleep disturbance and depression were risk 
factors for fatigue. The mean scores of these symptoms 
among fatigued patients were higher than among non-
fatigued patients. In the same manner, performance 
status was worse among fatigued than among non-
fatigued subjects. Various studies in different scenarios 
also identified performance status, pain, depression 
and sleep alteration, among others, as factors related 
to fatigue(4,6,11,14).
The discussion on the relation between fatigue 
and depression should be raised. Studies have 
attempted to identify cause-effect relations between 
these symptoms, but no conclusion has been reached. 
What is clear is that there is a positive and moderate/
strong correlation between them and that the rate of 
comorbidity fatigue/depression is harmful. Yet, some 
may consider the assessment of depression in cancer 
patients through the BDI as doubtful, due to the 
number of items that investigate somatic issues, which 
might cause confusion between depression and cancer 
symptoms. But this instrument was chosen because of 
its wide acceptance and utilization in cancer research.
The variables gender, age, marital status, skin 
color, education, employment status, family income, 
clinical cancer site, medical treatments, body mass 
index, level of hemoglobin, presence of illnesses in 
co-morbidities, use of antidepressants or anti-anxiety 
drugs and colostomy did not relate to fatigue. There 
are studies that observed some of these variables 
as risk factors for fatigue, such as female gender(18), 
young age(2,19), the absence of regular job(5), cancer 
treatment(2), among others. In other studies, other 
variables were also not observed, such as cancer 
staging, presence of some co-morbidities, concomitant 
medications, etc.(4,24). 
The greater or minor likelihood of a factor to 
predict an outcome (fatigue) can be calculated 
using logistic regression. Thus, by evaluating sleep, 
depression and performance status, the probability 
of the patient having fatigue can be observed in 
the Fatigue Predictors Table (Table 3). If the three 
predictive factors are present (sleep disturbance, 
depression and performance status), the chance a 
patient has fatigue is approximately 80%, and if none 
is present, the probability of fatigue occurrence is only 
8%. No study that presented the probability of fatigue 
could be found. The fact that only three variables were 
able to predict fatigue so accurately (80%) drew our 
attention and indicated that the model proposed in this 
paper is very useful to identify fatigue. Yet, there is 
still a need to investigate the factors that predict the 
fatigue of the other 20% of the patients.
The specificity of the model was good (81.9%), 
but the sensitivity of the model was moderate (58.6%), 
increasing chances of not diagnosing a fatigued 
patient. New studies are necessary, which attempt to 
identify other risk factors that increase the sensitivity 
of the model.  No study with logistic regressions for the 
predictive factors identifying fatigue in patients with 
rectal cancer was found and, among the three studies 
that used the logistic regression method involving 
Mota DDCF, Pimenta CAM, Caponero R.
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patients with other tumors, only one mentioned the 
discriminatory capacity of the model = 0.88(3). In that 
study, conducted with men with cancers in several 
sites, the predictors were sadness, dizziness, pain, 
appetite loss, irritability and dyspnea(3).
The risk factors “public health service” and pain 
were excluded from the logistic regression models. 
Not every risk factor is a predictive factor, because 
regression analysis distinguishes those that are 
important for an outcome occurrence (fatigue), in 
an independent way, from those that seem to be 
important for the phenomenon, but which in fact are 
surrogate to others. 
The findings of this search raised some issues: 1) 
If the sleep disturbance, the presence of depression 
and injury in performance status indicate the likelihood 
of a patient with colorectal cancer to have fatigue and 
if, 2) in oncology patients’ consultations, their sleep, 
depressive symptoms and functionality are quite often 
evaluated, it raises questions on the real need of using 
multidimensional scales, such as the Piper Fatigue 
Scale - revised, to diagnose fatigue. 
Based on the sleep, depression and performance 
status assessment results, the professional may, in 
fact, estimate the probability of the patient havinh 
fatigue or not, with high specificity (81.9%). However, 
in view of the model’s moderate sensitivity (58.6%), 
which increases the chance of a false negative, a 
strategy to deal with this situation is necessary. 
The use of a numerical scale for the evaluation of 
fatigue may be an alternative to the long instruments 
that exist to confirm the presence and severity of 
fatigue. It has the advantage of being fast and feasible, 
reducing the barriers for symptom assessment and 
streamlining the diagnosis in care and research. In this 
study, the correlation between the numerical fatigue 
scale and the Piper Fatigue Scale – revised was tested 
and a high correlation (r=0.748; p<0.001) was noted, 
which indicates that it can be useful on a daily base 
during care delivery to cancer patients. The main 
limitation of the numerical scale is the lack of details 
about the symptom, which could be obtained with the 
help of multidimensional instruments. 
Some limitations of this study can be appointed. 
The study was cross-sectional and the sample was not 
randomized; the way the variable “cancer treatment” 
was dichotomized - receiving adjuvant chemotherapy 
or radiotherapy or not - might have covered some 
difference between individuals receiving specific anti-
cancer treatments; and there was no investigation on 
gastrointestinal symptoms (e.g. diarrhea, constipation). 
The inclusion of patients using concomitant 
medications, such as antidepressants and anti-anxiety 
medications, may be questioned, since these may 
influence the presence and intensity of fatigue. Still, 
the inclusion of inpatients with colorectal cancer is 
desirable, considering that the results of the predictors 
and risk factors might be broader in this population. 
Such limitations need to be overcome in future studies. 
Despite these limitations, the researchers believe that 
the results can be generalized to other Brazilian or non-
Brazilian cancer patients, as the patients included in 
this study showed a profile similar to patients included 
in other international studies. The identification of 
fatigue predictors in colorectal cancer outpatients from 
other countries could help to validate the findings of 
this study. Yet, future research might as well test the 
Fatigue Prediction Table. A cohort study would be the 
ideal method to validate the findings of this search and 
improve the fatigue diagnostic strategies in clinical 
practice.
Based on this study, some progress can be pointed 
out and the implications for the practice are diverse. 
The first nursing publication about fatigue in Brazil was 
on laryngeal cancer(25). Now, for the first time in our 
country, the prevalence of fatigue was determined in 
patients with colorectal cancer, and a cut-off score for 
fatigue diagnosis was established. In an international 
scope, some results are innovative, as the independent 
fatigue predictors were not known in outpatients with 
colorectal cancer. This study presents the Fatigue 
Prediction Table, which permits investigating the 
probability of fatigue occurrence and contributes to 
symptom control. Sleep disturbance, depression and 
poor performance status together predicted 80% of 
fatigue cases in colorectal cancer situations, which is 
very good. Depression increased the risk of fatigue by 
four times, and sleep disturbance and performance 
status by three times. Due to the moderate sensitivity 
result of the model (58%), there is a considerable 
chance of having false negatives, which perhaps can 
be minimized by using a numerical scale from 0 to 10, 
in which score ≤4 indicates fatigue.
Conclusions
The prevalence of fatigue among colorectal cancer 
patients was 26.8%. Fatigue predictors were sleep 
disturbance, depression and performance status. 
When all factors were present, the chance a patient 
had fatigue was 80%, which indicated good prediction. 
When all factors were absent, the chance a patient had 
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fatigue was 8%. Depression increased the risk of fatigue 
fourfold, and sleep disturbance and performance status 
threefold. The specificity of the prediction model was 
very good, and the sensitivity was moderate.
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